| Avalyn Pharma Inc. | 1.7M | US$48.4M | 9.0% |
| Bristol-Myers Squibb Company | 500K | US$31.2M | 5.8% |
| BridgeBio Pharma, Inc. | 425K | US$28M | 5.2% |
| Parabilis Medicines, Inc. | 824K | US$26.6M | 4.9% |
| Johnson & Johnson | 99,496 | US$26.3M | 4.9% |
| Arrowhead Pharmaceuticals, Inc. | 315K | US$20.6M | 3.8% |
| Syndax Pharmaceuticals, Inc. | 1.02M | US$19.2M | 3.6% |
| Definium Therapeutics, Inc. | 498K | US$19M | 3.5% |
| Celcuity Inc. | 231K | US$18.3M | 3.4% |
| Septerna, Inc. | 454K | US$17.8M | 3.3% |
| Guardant Health, Inc. | 92,579 | US$16.5M | 3.1% |
| Protagonist Therapeutics, Inc. | 112K | US$15.8M | 2.9% |
| 10x Genomics, Inc. | 164K | US$14.8M | 2.8% |
| Amylyx Pharmaceuticals, Inc. | 506K | US$14.7M | 2.7% |
| Mineralys Therapeutics, Inc. | 583K | US$14.7M | 2.7% |
| Edwards Lifesciences Corporation | 161K | US$13.9M | 2.6% |
| Corvus Pharmaceuticals, Inc. | 1.02M | US$11.8M | 2.2% |
| Veradermics, Incorporated | 95,646 | US$11.6M | 2.2% |
| Disc Medicine, Inc. | 173K | US$11.3M | 2.1% |
| Odyssey Therapeutics, Inc. | 458K | US$10.2M | 1.9% |
| 4D Molecular Therapeutics, Inc. | 685K | US$9.8M | 1.8% |
| Ultragenyx Pharmaceutical Inc. | 602K | US$9.04M | 1.7% |
| BioMarin Pharmaceutical Inc. | 145K | US$8.7M | 1.6% |
| Annexon, Inc. | 1.99M | US$8.4M | 1.6% |
| Rhythm Pharmaceuticals, Inc. | 85,614 | US$8.15M | 1.5% |
| Structure Therapeutics, Inc. | 260K | US$8.13M | 1.5% |
| Nektar Therapeutics | 127K | US$7.68M | 1.4% |
| Immunocore Holdings plc | 212K | US$6.42M | 1.2% |
| Cogent Biosciences, Inc. | 168K | US$5.37M | 1.00% |
| Kailera Therapeutics, Inc. | 469K | US$5.35M | 0.99% |
| Natera, Inc. | 12,530 | US$5.18M | 0.96% |
| Fractyl Health, Inc. | 8.84M | US$4.81M | 0.89% |
| Kardigan, Inc. | 313K | US$4.61M | 0.86% |
| Eledon Pharmaceuticals, Inc. | 1.64M | US$4.14M | 0.77% |
| Heartflow, Inc. | 74,969 | US$3.73M | 0.69% |
| BridgeBio Oncology Therapeutics, Inc. | 700K | US$2.87M | 0.53% |
| Freenome, Inc. | 158K | US$2.49M | 0.46% |
| Protara Therapeutics, Inc. | 512K | US$1.56M | 0.29% |
| Karyopharm Therapeutics Inc. | 976K | US$1.19M | 0.22% |
| Hyperfine, Inc. | 1.3M | US$1.05M | 0.20% |
| Metagenomi Therapeutics, Inc. | 529K | US$561K | 0.10% |
| Sensei Biotherapeutics, Inc. | 14,718 | US$438K | 0.08% |
| Outset Medical, Inc. | 107K | US$322K | 0.06% |
| ADARx Pharmaceuticals, Inc. | 11,357 | US$226K | 0.04% |
| AtaiBeckley Inc. | 0 | US$0 | 0.00% |
| Axsome Therapeutics, Inc. | 0 | US$0 | 0.00% |
| Dianthus Therapeutics, Inc. | 0 | US$0 | 0.00% |
| Dyne Therapeutics, Inc. | 0 | US$0 | 0.00% |
| Gilead Sciences, Inc. | 0 | US$0 | 0.00% |
| Incyte Corporation | 0 | US$0 | 0.00% |